Universal Navigation

Join or Renew Your Membership Join Now

S23 - Genetic Muscle Disorders

Event Time:	Monday May 6, 2019 3:30 pm to 5:30 pm
Topic(s):	Neuromuscular and Clinical Neurophysiology (EMG)
Director(s):
Description:
Completion Message:
CME Credits:	2
Core Competencies:

Program Speakers - Tentative
Start/End Time	Title	Faculty
5:10 PM - 5:30 PM	Q&A Panel with Authors	Faculty

Disclosures
Speaker	Disclosure

Abstract Presenters
Start Time	Pub.	Title	Presenter
3:30 PM	002	Sensitive Assessment of Duchenne Muscular Dystrophy Progression with a Dedicated Electrical Impedance Myography Device	Disclosure: Dr. Rutkove has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Myolex, Biogen, Axcella Health, Merck. Dr. Rutkove has received personal compensation in an editorial capacity for Annals of Neurology. Dr. Rutkove has received compensation for serving on the Board of Directors of Myolex, Inc. Dr. Rutkove holds stock and/or stock options in Myolex, Inc.
3:30 PM	003	Genetic Prevalence of Myotonic Dystrophy Type 1	Disclosure: Dr. Johnson has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Acceleron, Strongbridge, Vertex, Fulcrum, and AveXis. Dr. Johnson has received personal compensation in an editorial capacity for Continuum. Dr. Johnson has received royalty, license fees, or contractual rights payments from University of Rochester. Dr. Johnson has received research support from Acceleron, CSL Behring, Fulcrum, Vertex, and AveXis.
3:30 PM	004	Breaking the sound barrier of randomized, controlled trials in congenital myopathies: results of the N-acetylcysteine trial in RYR1-related disorders	Disclosure: Dr. Todd has nothing to disclose.
3:30 PM	005	An Instrumented Timed Up and Go is Sensitive to Progression in Facioscapulohumeral Dystrophy	Disclosure: Dr. Statland has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Acceleron Pharma, Inc., Expansion Therapeutics, , Fulcrum Therapeutics, Genea Biocells, and Strongbridge Biopharma. Dr. Statland has received research support from FSH Society, Muscular Dystrophy Association, and the National Institutes of Health.
3:30 PM	006	FTX-1821 for Treatment of FSHD at its Root Cause: Results of a Clinical Trial in a Dish	Disclosure: Dr. Mellion has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Fulcrum Therapeutics, Vertex Pharmaceuticals. Dr. Mellion holds stock and/or stock options in Vertex Pharmaceuticals which sponsored research in which Dr. Mellion was involved as an investigator. Dr. Mellion holds stock and/or stock options in Vertex Pharmaceuticals. Dr. Mellion has received research support from Fulcrum Therapeutics, Vertex Pharmaceuticals.
3:30 PM	007	Comparison of Symptom Profile in Patients with SCN4A and CLCN1 Nondystrophic Myotonias	Disclosure: Dr. Meyer has nothing to disclose.
3:30 PM	008	Open-Label Phase 2 Clinical Trial of ManNAc for GNE Myopathy	Disclosure: Dr. Carillo-Carrasco has received research support from Leadiant Biosciences.
3:30 PM	009	Progressive Degenerative Myofibrillar Myopathy in Knock-In Mice Expressing LDB3 p.A165V Protein: A Mouse Model for Markesbery-Griggs Distal Myopathy	Disclosure: Dr. Blech-Hermoni has nothing to disclose.

Ready to register for the 2019 AAN Annual Meeting?

Related Courses

Saturday, May 4, 2019
9:30 AM-11:30 AM
C12 - Clinical Approach to Muscle Disease I: Role of Antibodies, Muscle Imaging, and Genetic Testing Tahseen Mozaffar MD, FAAN
1:30 PM-3:30 PM
C25 - Clinical Approach to Muscle Disease II: Inflammatory Myopathies and Muscle Pathology Tahseen Mozaffar MD, FAAN

Sunday, May 5, 2019
7:00 AM-9:00 AM
C46 - Actualización en dolor de cabeza y trastornos neuromusculares (Update: Headache and Neuromuscular Disorder) Jose Merino MD, MPhil, FAAN, Dario Beltran MD, FAAN
C36 - Mastering EMG Waveform Recognition Skills in Just Two Hours! Devon Rubin MD, FAAN
1:00 PM-3:00 PM
C49 - Neurology Update I: Multiple Sclerosis, Sleep, and Neuromuscular Disease Ralph Jozefowicz MD, FAAN, Adam Quick MD
C47 - Evaluation and Management of Autonomic Disorders I: Autonomic Testing, Failure, and Peripheral Neuropathies Amanda Peltier MD, MS
S5 - Therapeutics in ALS and SMA
3:30 PM-5:30 PM
C65 - Evaluation and Management of Autonomic Disorders II: Diagnostic Approach and Treatments for Dysautonomia Amanda Peltier MD, MS

Monday, May 6, 2019
11:30 AM-6:30 PM
P2 - Poster Session 2
1:00 PM-3:00 PM
C101 - Clinical EMG I: Principles and Practice of NCS and Needle EMG Ruple Laughlin MD, FAAN
N2 - Neuroscience in the Clinic: Interpretations of Genetic Results Massimo Pandolfo MD, FAAN, Karen Marder MD, MPH, FAAN
3:30 PM-4:45 PM
S18 - Autonomic Disorders
3:30 PM-5:30 PM
C120 - Clinical EMG II: Case-based Clinical Applications of Nerve Conduction Studies and Needle Electromyography Ruple Laughlin MD, FAAN

Tuesday, May 7, 2019
7:00 AM-9:00 AM
C121 - Clinical EMG III: Nerve Conduction Criteria and Electrodiagnostic Approaches Mark Bromberg MD, PhD, FAAN
9:15 AM-11:30 AM
Clinical Trials Plenary Session Deborah Hall MD, PhD, FAAN, Holly Hinson MD, MCR, FAAN
11:30 AM-6:30 PM
P3 - Poster Session 3
1:00 PM-3:00 PM
C131 - Small Fiber Neuropathies: Sensory, Autonomic, and Both I: Focus on Autonomic Nervous System Christopher Gibbons MD, FAAN
S25 - Child Neurology: Spinal Muscular Atrophy: Treatments and Outcomes
1:00 PM-5:30 PM
C148 - Skills Workshop: EMG: Basic (Registration Required) Holli Horak MD, FAAN
3:30 PM-5:30 PM
C150 - Small Fiber Neuropathies: Sensory, Autonomic, and Both II: Focus on Sensory Nervous System Christopher Gibbons MD, FAAN
Presentation of the Sheila Essey Award: An Award for ALS Research

Wednesday, May 8, 2019
7:00 AM-9:00 AM
C171 - Child Neurology: Neuromuscular/Autoimmune Neurology Anne Connolly MD, FAAN
11:30 AM-6:30 PM
P4 - Poster Session 4
1:00 PM-3:00 PM
C175 - Neuromuscular Junction Disorders I: Myasthenia Gravis, Ocular, and MuSK Myasthenia Laura Tormoehlen MD, FAAN
N4 - Neuroscience in the Clinic: Immunotherapies in Neurological Disease Holly Hinson MD, MCR, FAAN, John Corboy MD, FAAN
1:00 PM-5:30 PM
C191 - Skills Workshop: Neuromuscular Ultrasound (Registration Required) Craig Zaidman MD
3:30 PM-5:30 PM
C192 - Neuromuscular Junction Disorders II: Toxins, Lambert-Eaton Syndrome and Less Common Disorders of Neuromuscular Transmission Laura Tormoehlen MD, FAAN
C195 - Therapy in Neurology II: Neurocritical Care and Neuromuscular Disease Madhu Soni MD, FAAN
S42 - Neuromuscular Disorders

Thursday, May 9, 2019
7:00 AM-9:00 AM
C205 - Peripheral Neuropathy I: Anatomical Basis and Acquired Demyelinating Neuropathies David Herrmann MD, FAAN
C214 - Child Neurology: A Case-based Approach Elaine Wirrell MD, FAAN
11:30 AM-6:30 PM
P5 - Poster Session 5
1:00 PM-3:00 PM
C215 - Peripheral Neuropathy II: Update on Diabetic, Immune Axonal, and Hematologic-related Neuropathies Michelle Mauermann MD, FAAN
3:30 PM-5:30 PM
C229 - Peripheral Neuropathy III: Genetic Neuropathies: Molecular Diagnosis and Treatment Perspectives Mario Saporta MD, PhD, FAAN
S54 - Motor Neuron Disease
7:00 PM-10:00 PM
C237 - Case Studies: Diagnosis and Management of Unusual Cases in Neuromuscular Disease Robert Pascuzzi MD, FAAN

Friday, May 10, 2019
7:00 AM-9:00 AM
C243 - Therapy of Neuromuscular Disease: ALS, Inflammatory Neuropathies and Myopathies, and Myasthenia Gravis Michael Weiss MD, FAAN
9:15 AM-11:30 AM
Neurology Year in Review Plenary Session Martinson Arnan MD
1:00 PM-3:00 PM
S58 - Therapeutics in Neuromuscular Disorders
2:00 PM-2:45 PM
Consensus-based Care Recommendations for Adults with Myotonic Dystrophy Type 1 Nicholas Johnson MD, FAAN
Consensus-Based Care Recommendations for Adults with haha

Footer